Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients

NCT03011177 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: Teneligliptin
DRUG: Linagliptin

Sponsor

Handok Inc.